Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F17073)

Formulation Name

Phenoxybenzamine 10 mg capsule

Company

WellSpring Pharmaceutical

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Phenoxybenzamine	DM8KSQH	Malignant essential hypertension	BA00	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	E00099	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
D&C red no. 33	E00261	19116	Colorant
FD&C red no. 3	E00629	Not Available	Colorant
Silicon dioxide	E00670	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	E00464	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sunset yellow FCF	E00255	17730	Colorant

--------------------